• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Influx Healthtech Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
93847
INE0MYZ01012
43.5242588
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INFLUX
31.97
656.55
EPS(TTM)
Face Value()
Div & Yield %
8.87
10
0
 

GSB Finance standalone net profit rises 38.46% in the December 2025 quarter
Jan 29,2026
Net profit of GSB Finance rose 38.46% to Rs 0.18 crore in the quarter ended December 2025 as against Rs 0.13 crore during the previous quarter ended December 2024. Sales declined 29.55% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 0.44 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales0.310.44 -30
OPM %48.3945.45 -
PBDT0.150.17 -12
PBT0.150.17 -12
NP0.180.13 38